Ms. Baglaneas has more than a decade of experience in corporate communications, investor relations and public relations in the healthcare industry, partnering with executive leadership teams to develop and execute on strategic communications plans for companies of all sizes and stages. Prior to joining Rezolute, she led the corporate communications and investor relations function at Theseus Pharmaceuticals, a targeted oncology biopharmaceutical company, working with leadership to expand investor base and craft corporate and program-specific messaging through IPO and clinical data readouts. Prior to Theseus, Ms. Baglaneasserved in roles of increasing responsibility spearheading investor relations and corporate communications strategy for biotech companies, leading the PR efforts for the life sciences and corporate transactions practice groups of global law firm, Morgan Lewis, and managed the PR for a Congressional campaign in Massachusetts.
She holds a B.A. in English Literature and Art History from Providence College.